Published in BMC Cancer on May 11, 2008
Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer | NCT00596895
Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. JAMA (2013) 3.40
Perspectives for cancer prevention with natural compounds. J Clin Oncol (2009) 1.99
Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev (2010) 1.29
Clinical development of novel proteasome inhibitors for cancer treatment. Expert Opin Investig Drugs (2009) 1.22
Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol (2013) 1.13
Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev (2009) 1.13
Phytochemicals in cancer prevention and therapy: truth or dare? Toxins (Basel) (2010) 1.10
Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutr Cancer (2010) 1.00
Chemoprevention of prostate cancer: Natural compounds, antiandrogens, and antioxidants - In vivo evidence. J Carcinog (2011) 0.97
Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr Pharm Des (2010) 0.97
Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer (2010) 0.96
Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor. Asian J Androl (2010) 0.90
Estrogens and prostate cancer: etiology, mediators, prevention, and management. Endocrinol Metab Clin North Am (2011) 0.88
A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol (2015) 0.87
Does equol production determine soy endocrine effects? Eur J Nutr (2012) 0.87
Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer. PLoS One (2011) 0.87
The role of soy in vegetarian diets. Nutrients (2010) 0.86
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature. Nutrients (2016) 0.85
Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. Am J Clin Nutr (2014) 0.83
Perspectives on the role of isoflavones in prostate cancer. AAPS J (2013) 0.82
Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivo evidence. Reprod Biol Endocrinol (2011) 0.82
Anti-androgenic effects of flavonols in prostate cancer. Ecancermedicalscience (2015) 0.79
Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics (2015) 0.78
Isoflavone Pharmacokinetics and Metabolism after Consumption of a Standardized Soy and Soy-Almond Bread in Men with Asymptomatic Prostate Cancer. Cancer Prev Res (Phila) (2015) 0.76
Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell line. J Biomed Sci (2016) 0.76
Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey. Nutr Cancer (2013) 0.76
Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects? Int J Mol Sci (2017) 0.75
Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst (1968) 4.68
Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys (1997) 4.58
Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer (1994) 3.38
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev (2006) 2.48
Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res (1995) 2.34
Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol (1991) 2.10
Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation (2006) 2.07
Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol (1994) 1.94
Risk factors for prostate cancer. Ann Intern Med (1993) 1.90
Soybean phytoestrogen intake and cancer risk. J Nutr (1995) 1.72
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev (1998) 1.69
Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) J Urol (1998) 1.40
Soy isoflavones in the treatment of prostate cancer. Nutr Cancer (2003) 1.24
Phase II trial of celecoxib in prostate-specific antigen recurrent prostate cancer after definitive radiation therapy or radical prostatectomy. Clin Cancer Res (2006) 1.22
Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta (1996) 1.07
Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem (2006) 1.04
Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr Cancer (2005) 1.03
25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol (2002) 1.01
Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk. Eur J Cancer (2006) 0.98
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology (2006) 0.97
Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro. Nutr Cancer (2006) 0.93
Inhibitors for protein-tyrosine kinases, ST638 and genistein: induce differentiation of mouse erythroleukemia cells in a synergistic manner. Exp Cell Res (1989) 0.90
The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer. Prostate Cancer Prostatic Dis (2005) 0.81
Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression. J Urol (2000) 0.79
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood (2009) 2.57
Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer. J Urol (2012) 2.12
Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res (2013) 2.00
Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS (2009) 1.91
Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS (2010) 1.79
Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation. Prostate (2008) 1.74
The incidence and clinical significance of nucleophosmin mutations in childhood AML. Blood (2007) 1.60
Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: a retrospective study. Leuk Lymphoma (2008) 1.57
Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One (2009) 1.57
Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature. BMC Urol (2013) 1.52
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Circ Cardiovasc Genet (2012) 1.52
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor. Cell Res (2006) 1.51
Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res (2011) 1.50
Imaging the urologic patient: the utility of intravenous pyelogram in the CT scan era. World J Urol (2013) 1.47
CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome. Leuk Lymphoma (2006) 1.45
BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J Cell Sci (2011) 1.44
Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics (2006) 1.44
A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. Cancer Res (2009) 1.42
Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol (2003) 1.41
The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility. Int Braz J Urol (2007) 1.38
Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. J Urol (2004) 1.36
Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res (2011) 1.34
Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis (2006) 1.32
Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J Cell Sci (2009) 1.29
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer (2009) 1.28
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study. Blood (2011) 1.25
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood (2007) 1.23
p37 Induces tumor invasiveness. Mol Cancer Ther (2005) 1.21
Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2005) 1.20
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer (2006) 1.20
Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery. J Urol (2012) 1.19
CCL18 in a multiplex urine-based assay for the detection of bladder cancer. PLoS One (2012) 1.18
Structure determination of the cancer-associated Mycoplasma hyorhinis protein Mh-p37. Acta Crystallogr D Biol Crystallogr (2008) 1.17
CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology (2009) 1.16
Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth. Prostate (2009) 1.14
Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urol (2009) 1.14
A general statistical framework for mapping quantitative trait loci in nonmodel systems: issue for characterizing linkage phases. Genetics (2003) 1.12
Relationship Risks in Context: A Cumulative Risk Approach to Understanding Relationship Satisfaction. J Marriage Fam (2008) 1.11
Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts. Mol Cancer Ther (2007) 1.11
Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study. Gastrointest Endosc (2012) 1.10
Smoothelin immunohistochemistry is a useful adjunct for assessing muscularis propria invasion in bladder carcinoma. Histopathology (2010) 1.10
A multi-analyte assay for the non-invasive detection of bladder cancer. PLoS One (2012) 1.10
Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells. Med Oncol (2010) 1.10
Outcome from a prospective, longitudinal study of prenatal cocaine use: preschool development at 3 years of age. J Pediatr Psychol (2005) 1.10
A candidate molecular biomarker panel for the detection of bladder cancer. Cancer Epidemiol Biomarkers Prev (2012) 1.10
Growth failure and outcome in Rett syndrome: specific growth references. Neurology (2012) 1.10
IL-8 as a urinary biomarker for the detection of bladder cancer. BMC Urol (2012) 1.09
Quantitative trait loci for growth trajectories in Populus. Genet Res (2003) 1.08
Modeling sequence-sequence interactions for drug response. Bioinformatics (2007) 1.08
Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Lab Invest (2013) 1.07
PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation. J Cell Sci (2009) 1.07
Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection. Urology (2012) 1.06
Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors. Cancer Res (2012) 1.06
Predicting caregiver-reported behavior problems in cocaine-exposed children at 3 years. J Dev Behav Pediatr (2006) 1.06
Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group. J Clin Oncol (2009) 1.06
A field study of bar-sponsored drink specials and their associations with patron intoxication. J Stud Alcohol Drugs (2009) 1.06
Protease-activated receptor 2 signalling pathways: a role in pain processing. Expert Opin Ther Targets (2013) 1.05
Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. J Nutr (2006) 1.05
Complete genome sequence of the bacterium Ketogulonicigenium vulgare Y25. J Bacteriol (2010) 1.04
Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. Oncol Rep (2010) 1.04
Magnetic resonance imaging for axillary staging in patients with breast cancer. J Magn Reson Imaging (2009) 1.03
Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer. BMC Cancer (2011) 1.02
Paper based point-of-care testing disc for multiplex whole cell bacteria analysis. Biosens Bioelectron (2011) 1.02
Structural insights into the extracytoplasmic thiamine-binding lipoprotein p37 of Mycoplasma hyorhinis. J Bacteriol (2009) 1.02
A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain. Support Care Cancer (2013) 1.01
Multiplex protein signature for the detection of bladder cancer in voided urine samples. J Urol (2013) 1.01
[Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano (2010) 1.00
Functional mapping of quantitative trait loci that interact with the hg mutation to regulate growth trajectories in mice. Genetics (2005) 1.00
Prospective evaluation of the clinical utility of ERCP-guided cholangiopancreatoscopy with a new direct visualization system. Gastrointest Endosc (2011) 1.00
Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther (2010) 1.00
Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling. J Bone Miner Res (2010) 1.00
Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. BMC Cancer (2013) 0.99
Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor. Intern Med (2012) 0.99
Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage. Toxicol In Vitro (2011) 0.98
Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol Cancer Ther (2013) 0.98
Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology (2004) 0.97
Phase II trial of dolastatin-10 in patients with advanced breast cancer. Invest New Drugs (2005) 0.97
Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. J Exp Clin Cancer Res (2011) 0.97
Estrogen receptor-alpha polymorphisms and predisposition to TMJ disorder. J Pain (2009) 0.97
Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests. Mol Diagn Ther (2013) 0.96
The utility of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. Gastroenterol Res Pract (2010) 0.96
L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo. J Innate Immun (2012) 0.96
Complete Genome Sequence of the Industrial Strain Gluconobacter oxydans H24. Genome Announc (2013) 0.95